Concomitant Chemoradiotherapy as Primary Therapy for Advanced Head and Neck Cancer |
Lee Joo-Yun
(Department of Otolaryngology, College of Medicine Chungbuk National University)
Lee Dong-Wook (Department of Otolaryngology, College of Medicine Chungbuk National University) Choi Young-Seok (Department of Otolaryngology, College of Medicine Chungbuk National University) Jin Hong-Ryul (Department of Otolaryngology, College of Medicine Chungbuk National University) Lee Hyun-Seok (Department of Otolaryngology, College of Medicine Chungbuk National University) Yeon Je-Yeob (Department of Otolaryngology, College of Medicine Chungbuk National University) Shin See-Ok (Department of Otolaryngology, College of Medicine Chungbuk National University) |
1 | Lefebvre JL, Chevalier D, Luboinski B. Kirkpatrick A, Collette L, Sahmoud T : Larynx preservation in pyriform sinus cancer : preliminary results of a European organization for reserch and treatment of cancer phase III trial. JU of Natl Cancer inst. 1996 ; 88: 890-899 DOI ScienceOn |
2 | Begg AC, Van der Kolk PJ, Dewit L, Bartelink H : Radiosensitization by cisplatin of RIF1 tumour in vitro. Int J radiat Biol Relat Stud Phys Chem Med 1986 ; 50 (5) : 871-884 DOI PUBMED |
3 | Pignon JP, Bourhis J, Domenge C, Designe L : Chemotherapy as an adjunct to definitive locoregional treatment for head and neck squamous cell carcinoma ; result of three meta-analysis using updated individual data. Lancet 2000 ; 14 : 838-844 |
4 | Lavertu, Pierre, adelstein, David J, et al : Aggressive concurrent chemoradiothrapy for squamous cell head and neck cancer : An 8-year single-institution experience. Arch Otolaryngol Head Nck Surg. 1999 ; 125 (2) : 142-148 DOI |
5 | Schaake-Koning C, Gogaet W, Dalesio O, et al : Effect of con-comittant cisplatin and radiotherpy on inoperable non-small cell lung cancer. N eng J Med 1992 ; 326 : 524-530 DOI ScienceOn |
6 | Adelstein DJ, Saxton JP, Lavertu P, et al : A phase II randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer : preliminary results. Head and Neck. 1997 ; 19 : 567-575 DOI ScienceOn |
7 | Tavorath R, Pfister DG : Chemotherapy for recurrent disease and combined modality therapies for head and neck cancer. Curr Opin Oncol. 1995 ; 7 : 242-247 DOI ScienceOn |
8 | Asegawa Y, Matssura H, Kano M, Shimozato K : A randomized trial of neoadjuvant chemotherapy with cisplatin and 5-FU in advanced head andneck cancer. Proc Am Soc Cli Oncol. 1994 ; 13 : 286 |
9 | Koness RJ, Glicksman A, Liu L, et al : Recurrence patterns with concurrent platinum- based chemothrapy and accelerated hyper-fractionated radiotherapy in stage III and IV head and neck cancer patients. Am J Surg. 1997 ; 174 : 532-535 DOI ScienceOn |
10 | Vokes EE, Pajak TF : Enhancing the therapeutic index of concomitant chemoradiotherapy for Head and Neck cancer: Ann Oncol. 1998 ; 9 : 471-474 |
11 | Department of Veterans Affairs Laryngeal Study Group. Induction chemotherapy plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991 ; 324 : 1685-1690 DOI ScienceOn |
12 | Shah JP, Ladd W : Treatment of cancer of the head and neck cancer : the role of chemotherapy. Crit Rev Oncol Hematol. 1996 ; 24 : 97-116 DOI ScienceOn |
13 | Lawrence TS, Davis MA, Maybaum J : Dependence of 5-fluorouracil-mediated radiosensitization on DNA-directed effects. Int J Radiat Oncol Biol Phys. 1994 ; 29 (3) : 519-523 DOI PUBMED ScienceOn |
14 | Calais G, Alfonsi M, Bardet E, et al : Randomized study compairing radiation alone (RT) versus RT with concomitant chemotherapy (CT) in stage III and IV oropharynx carcinoma (ARCORO) : preliminary results of the 94.01 study from the French Group of Radiation Oncology for Head and Neck cancer (GORTC). Proc Am Soc Clin Oncol. 1998 ; 17 : 385a (abstr 1484) |
15 | Head and Neck Contracts Program: Adjuvant chemotherapy for advanced head and neck squamous cell carcinoma. Cancer. 1987 ; 60 : 301-311 DOI PUBMED ScienceOn |
16 | AI-sarraf M, LeBlanc M, Giri PGS, et al : Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer : Phase III randomized intergroup 0099. J Clin Oncol. 1998 ; 16 : 1310-1317 DOI |
17 | Adelstein DJ, Tan EH, Lavertu P : Treatment cancer of head and neck cancer. Cancer J Clin. 1995 ; 45 : 352-368 DOI ScienceOn |
18 | Lavertu, Pierre, Adelstein, et al : Aggressive Concurrent Chemoradiotherapy for Squamous Cell Head and Neck Cancer : An 8-year single-institution experience, Arch Otlaryngol Head and Neck Surg. 1999 ; 125 (2) : 142-148 DOI |